Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Te Lu

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Nature Nanotechnology|November 20, 2019
Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapiesYun-Chieh Sung, Pei-Ru Jin, Li-An Chu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 10, 2025
Recommendation for the use of respiratory syncytial virus vaccinesPing-Ing Lee, Yhu-Chering Huang, Ching-Chuan Liu, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010Jien-Wei Liu, Wen-Chien Ko, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010Yen-Hsu Chen, Po-Liang Lu, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010Hsih-Yeh Tsai, Chun-Hsing Liao, Yen-Hsu Chen, et al.
International Journal of Antimicrobial Agents|July 16, 2013
Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010Hsih-Yeh Tsai, Yen-Hsu Chen, Chun-Hsing Liao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 13, 2024
Surveillance of pathogenic yeasts in hospital environments in Taiwan in 2020De-Jiun Tsai, Li-Yun Hsieh, Pei-Jung Chung, et al.
Diagnostic Microbiology and Infectious Disease|July 24, 2014
Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010Shin-Ming Tsao, Wei-Yao Wang, Wen-Chien Ko, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Nature Nanotechnology|November 20, 2019
Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapiesYun-Chieh Sung, Pei-Ru Jin, Li-An Chu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 10, 2025
Recommendation for the use of respiratory syncytial virus vaccinesPing-Ing Lee, Yhu-Chering Huang, Ching-Chuan Liu, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010Jien-Wei Liu, Wen-Chien Ko, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010Yen-Hsu Chen, Po-Liang Lu, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010Hsih-Yeh Tsai, Chun-Hsing Liao, Yen-Hsu Chen, et al.
International Journal of Antimicrobial Agents|July 16, 2013
Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010Hsih-Yeh Tsai, Yen-Hsu Chen, Chun-Hsing Liao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 13, 2024
Surveillance of pathogenic yeasts in hospital environments in Taiwan in 2020De-Jiun Tsai, Li-Yun Hsieh, Pei-Jung Chung, et al.
Diagnostic Microbiology and Infectious Disease|July 24, 2014
Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010Shin-Ming Tsao, Wei-Yao Wang, Wen-Chien Ko, et al.
Pageof 17